Nephros Profit Margin

Nephros (NEPH) currently reports a profit margin of 8.38% as of June 2026. That compares with 7.95% in the prior-year period — up 5.3% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Nephros's profit margin history and peer comparisons.

Nephros's profit margin increased from 7.95% to 8.38% — a 5.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nephros's profit margin of 8.38% is lower than the Healthcare sector average of 21.34%. That is roughly 60.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Nephros's current 8.38% should be judged against Healthcare norms (sector average: 21.34%) and against NEPH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 8.38%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Nephros, and consider following NEPH for alerts when major investors trade the stock.